<DOC>
	<DOC>NCT01396265</DOC>
	<brief_summary>The objective of the current study is to investigate the effect of the P-gp inducer rifampicin on the pharmacokinetics (PK) of afatinib in healthy male volunteers</brief_summary>
	<brief_title>Drug Interaction Study With Rifampicin and Afatinib</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<criteria>Inclusion criteria: Healthy male volunteers Exclusion criteria: Any relevant deviations from healthy conditions</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>